This Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $1,399,500.00 to The Washington University's Office of Sponsored Research Services Division to research and develop an engineered interleukin-2/receptor complex for the treatment of chronic migraine and post-traumatic headache. The award period runs from September 1, 2023 through August 31, 2027.
The Washington University has extensive experience managing federal grants and contracts, including past awards from the National Institutes of Health, National Aeronautics and Space Administration, and Substance Abuse and Mental Health Services Administration for biomedical, education, and community-focused projects. The university also holds an indefinite delivery/indefinite quantity contract with the Department of Veterans Affairs to provide research training and mentoring services.
Generated 4/23/24, 8:09 AM